Peer Review reports
From: Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study
| Original Submission | ||
|---|---|---|
| 6 Jul 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 8 Sep 2023 | Author responded | Author comments - Tsubasa Takizawa |
| Resubmission - Version 3 | ||
| 8 Sep 2023 | Submitted | Manuscript version 3 |
| 25 Sep 2023 | Reviewed | Reviewer Report - Takao Takeshima |
| 30 Sep 2023 | Reviewed | Reviewer Report |
| 16 Oct 2023 | Author responded | Author comments - Tsubasa Takizawa |
| Resubmission - Version 4 | ||
| 16 Oct 2023 | Submitted | Manuscript version 4 |
| 17 Oct 2023 | Author responded | Author comments - Tsubasa Takizawa |
| Resubmission - Version 5 | ||
| 17 Oct 2023 | Submitted | Manuscript version 5 |
| 25 Oct 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 26 Oct 2023 | Editorially accepted | |
| 14 Nov 2023 | Article published | 10.1186/s12883-023-03449-3 |
You can find further information about peer review here.